Skip to main content
    N

    National Health Investors Inc (NHI)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $60.03
    -0.74 (-1.22%)

    Market Cap: $2.98B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    National Health Investors Inc (NHI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    National Health Investors (NHI) has a market cap of $2.98B and a P/FFO of 12.1x on its 2026 FFO estimate. It kept 152.78% of revenue as net income over the last 12 months. Revenue grew 28.70% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 33.30% above the market cap, as debt exceeds cash.

    Market Cap$2.98B
    Enterprise Value$3.98B
    Latest price (Nov 17, 2026)$60.03

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Next Ex-Dividend DateDec 31, 2026
    Next Payment DateJan 29, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.24% in the quarter ended Sep 30, 2026 and grew 6.20% a year over 2 years.

    Shares Outstanding49.04M
    Shares Change (YoY)+3.38%
    Shares Change (QoQ)+1.24%
    Share Count Growth (2Y CAGR)+6.20%

    Valuation Ratios

    P/FFO is 12.1x on the 2026 FFO estimate of $4.96 a share. Its year-end P/S ranged from 7.6x to 11.7x from 2016 to 2025.

    P/FFO (2026 estimate)12.1x
    Forward P/E16.7x
    P/S Ratio6.5x
    Forward P/S6.7x
    P/B Ratio1.4x
    P/OCF Ratio12.7x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 4.5x EBITDA.

    EV / Earnings5.7x
    EV / Sales8.7x
    EV / EBITDA4.5x
    EV / EBIT5.1x

    Price Statistics

    The stock is down 20.36% over 52 weeks and trades 9.82% below its 50-day average.

    Beta (1Y)-0.22
    52-Week Change-20.36%
    1-Month Change-7.22%
    3-Month Change-17.81%
    6-Month Change-19.64%
    5-Year Change+24.66%
    10-Year Change-11.51%
    Total Return (1Y)-15.45%
    Total Return (3Y CAGR)+7.44%
    Total Return (5Y CAGR)+6.00%
    Return vs SPY (1Y)-33.09%
    Max Drawdown (1Y)-32.49%
    Max Drawdown (3Y)-32.49%
    Sharpe Ratio (1Y)-0.97
    Correlation with SPY (1Y)-0.12
    50-Day Average$66.57
    200-Day Average$74.44
    52-Week Range$60.53 to $88.03
    RSI (14 Days)28.5
    Average Volume (20 Days)360.37K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.51x current liabilities, and total debt is 0.50x shareholder equity.

    Current Ratio0.51x
    Quick Ratio0.51x
    Debt / Equity0.50x
    Debt / EBITDA1.18x
    Interest Coverage3.39x

    Returns and Efficiency

    Return on invested capital is 19.71% over the last 12 months, against a 5-year average of 5.72%.

    Return on Equity (ROE)33.31%
    Return on Assets (ROA)21.46%
    Return on Invested Capital (ROIC)19.71%
    Return on Capital Employed (ROCE)24.77%
    ROE (5Y Average)8.51%
    ROA (5Y Average)4.44%
    ROIC (5Y Average)5.72%
    Asset Turnover0.15x

    Taxes

    Income tax took 0.15% of pretax income over the last 12 months.

    Income Tax (TTM)$1.01M
    Effective Tax Rate0.15%

    Scores

    NHI has a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    FFO per share was $4.74 for 2025, the latest reported year. Revenue was $455.64M over the last 12 months.

    FFO Per Share (2025)$4.74
    Revenue$455.64M
    Revenue Growth (YoY)+28.70%
    Gross Profit$455.64M
    Operating Income$210.67M
    Pretax Income$694.81M
    Net Income$696.13M
    EBITDA$879.25M
    EBIT$780.93M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 64.51% of the $3.24B in total assets.

    Cash and Equivalents$46.56M
    Total Debt$1.04B
    Net Debt$993.77M
    Net Debt Per Share$20.27
    Working Capital-$44.73M
    Shareholder Equity$2.09B
    Book Value Per Share$42.62
    Total Assets$3.24B
    Total Liabilities$1.14B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $391.00M of capital spending, operating cash flow left -$156.88M of free cash flow.

    Operating Cash Flow$234.12M
    Capital Expenditures$391.00M
    Free Cash Flow-$156.88M
    FCF Per Share-$3.19
    Depreciation and Amortization$100.02M
    Dividends Paid$178.61M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 46.24%, against a 5-year average of 42.09%.

    Gross Margin100.00%
    Operating Margin46.24%
    Pretax Margin152.49%
    Net Margin152.78%
    EBITDA Margin192.97%
    EBIT Margin171.39%
    FCF Margin-34.43%
    Operating Margin (5Y Average)42.09%
    Net Margin (5Y Average)35.82%

    Growth

    FFO per share grew 1.00% a year over 3 years, and revenue 7.01% a year.

    FFO Per Share Growth (3Y CAGR)+1.00%
    Revenue Growth (3Y CAGR)+7.01%
    Revenue Growth (5Y CAGR)+2.45%
    EPS Growth (3Y CAGR)+20.74%
    EPS Growth (5Y CAGR)-1.50%
    Operating Income Growth (3Y CAGR)+44.22%
    Book Value Per Share Growth (2Y CAGR)+5.78%
    Tangible Book Per Share Growth (2Y CAGR)+5.78%

    Revenue and profit by year

    Dividends and Yields

    NHI pays out 79.32% of 2025 FFO as dividends.

    Dividend Per Share (Annual)$3.76
    Dividend Yield6.26%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+0.37%
    Dividend Growth (5Y CAGR)-3.77%
    Payout Ratio (2025 FFO)79.32%
    FFO Yield (2025)7.90%
    FCF Yield-5.33%
    Buyback Yield-3.15%
    Shareholder Yield2.92%

    Full dividend history

    Peer Position

    Against 12 similar companies, NHI has the 5th highest P/FFO and the 3rd highest P/S.

    P/FFO12.1x vs 11.0x median
    P/S Ratio6.5x vs 4.9x median
    ROIC19.71% vs 4.25% median
    Revenue Growth (Trailing 4 Quarters, YoY)+28.70% vs +10.13% median
    Dividend Yield6.26% vs 5.87% median

    Competitors compared

    Analyst Forecast

    FFO per share estimates imply 4.64% growth a year over the next 2 years. Consensus estimates put revenue growth at 13.66% a year over the next 2 fiscal years.

    FFO Per Share Growth Forecast (2Y CAGR)+4.64%
    Revenue Growth Forecast (2Y CAGR)+13.66%
    EPS Growth Forecast (2Y CAGR)-6.28%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NHI

    What is NHI's market cap?

    National Health Investors has a market cap of $2.98B. Its enterprise value, which adds debt and subtracts cash, is $3.98B.

    What is NHI's price to FFO ratio?

    National Health Investors has a P/FFO of 12.1x on its 2026 FFO estimate.

    How many shares of NHI are outstanding?

    National Health Investors has 49.04M shares outstanding. The count is up 3.38% from a year earlier.

    Does NHI pay a dividend?

    Yes. National Health Investors pays $3.76 a share a year, a dividend yield of 6.26%.

    How much debt does NHI have?

    National Health Investors has $1.04B of total debt and $46.56M of cash and equivalents, a net debt position of $993.77M.